Course Information

Advances in Autism 2018
*COURSE IS SOLD OUT

Tamkin Auditorium
Ronald Reagan UCLA Medical Center
Los Angeles, California

April 20, 2018

*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.

Syllabus for Conference Registrants

Download: [ PDF ]

This full-day annual symposium is designed for all those interested in learning about the latest breakthroughs in research and treatment in autism spectrum disorder (ASD), including health care providers, teachers, autism service providers, and families. Nationally renowned UCLA Center for Autism Research and Treatment (CART) faculty, including Dr. Daniel Geschwind and Dr. Susan Bookheimer, will present the most up-to-date information about ASD across the lifespan, from early markers, diagnosis, and neurobiology to both behavioral and pharmacological interventions in children and adults. The talks will combine clinical expertise with insights gained from research. This continuing education symposium is designed to equip community practitioners to apply the most effective “best practices” for assessment, management and treatment of individuals with ASD.

Target Audience:
This full-day annual symposium is designed for all those interested in learning about the latest breakthroughs in research and treatment in autism spectrum disorder (ASD), including health care providers, teachers, autism service providers, and families.

Enrollment

Course is sold out as of April 16th. Please call 310-794-2620 to be placed on the wait list.

No onsite registrations will be accepted, no exceptions.

If your application (phone, fax, mail) is received after the course is sold out, you will be notified and placed on the wait list.

Course Fees

  • $195 Physicians
  • $165 Nurses and Allied Health Professionals
  • $90 Non-Healthcare

Refunds

Cancellations must be received in writing by Friday, March 30, 2018 and will be subject to a $50 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.

Symposium Chairs

Daniel H. Geschwind, MD, PhD
Gordon & Virginia MacDonald Distinguished Professor
Departments of Neurology, Psychiatry and Human Genetics*
Senior Associate Dean and Associate Vice Chancellor, Precision Health
Director, UCLA Center for Autism Research and Treatment (CART)

Susan Bookheimer, PhD
Joaquin Fuster Professor of Cognitive Neuroscience*
Director, Staglin IMHRO MRI Laboratory
Director, Intellectual and Developmental Disabilities Research Center
Department of Psychiatry and Biobehavioral Sciences
Co-Director, UCLA Center for Autism Research and Treatment (CART)

UCLA Course Faculty

Mirella Dapretto, PhD
Professor, Psychiatry and Biobehavioral Sciences*
UCLA Center for Autism Research and Treatment (CART)

Michelle Dean, PhD
Assistant Professor, Special Education
CSU Channel Islands

Charlotte DiStefano, PhD
Clinical Instructor*
Semel Institute for Neuroscience
UCLA Center for Autism Research and Treatment (CART)

Amanda Gulsrud, PhD
Assistant Clinical Professor, Psychiatry & Biobehavioral Sciences*
Clinical Director, Child and Adult Neurodevelopmental (CAN) Clinic
UCLA Center for Autism Research and Treatment (CART)

Shafali Spurling Jeste, MD
Associate Professor in Psychiatry, Neurology and Pediatrics*
Director, Developmental Neurophysiology Lab
UCLA Center for Autism Research and Treatment (CART)

Elizabeth Laugeson, PsyD
Associate Clinical Professor*
Founder and Director, UCLA PEERS Clinic
Training Director, UCLA Tarjan Center UCEDD
UCLA Center for Autism Research and Treatment (CART)

James T. McCracken, MD
Joseph Campbell Professor of Child Psychiatry*
Director, Division of Child and Adolescent Psychiatry
Department of Psychiatry and Biobehavioral Sciences
Semel Institute for Neuroscence
Director, Child and Adult Neurodevelopmental (CAN) Clinic
UCLA Center for Autism Research and Treatment (CART)

Julian A. Martinez-Agosto, MD, PhD, FACMG, FAAP
Associate Professor*
Department of Human Genetics
Division of Medical Genetics, Department of Pediatrics
Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior
Director, Developmental Neurogenetics Clinic
Co-Director, Pediatric Cancer Predisposition Clinic
UCLA Undiagnosed Diseases Program

Benjamin Schneider, MD
Assistant Clinical Professor*
Psychiatry and Biobehavioral Sciences
Associate Director, Child and Adult Neurodevelopment (CAN) Clinic
Medical Director, UCLA ABC Partial Hospitalization Program

*David Geffen School of Medicine at UCLA

Friday, April 20, 2018

9:15 Registration and Breakfast
9:45 Welcome and Introduction
Daniel H. Geschwind, MD, PhD
Genetics
10:00 Clinical Perspectives:
Diagnostic Genetic Testing and its Role in the Clinical Management of Autism
Julian A. Martinez-Agosto, MD, PhD, FACMG, FAAP
10:25 Research Updates:
Advances in the Genetics of Autism: Implications for Therapy
Daniel H. Geschwind, MD, PhD
Neuroimaging
10:50 Clinical Perspectives:
Update on Brain Research in Autism
Susan Bookheimer, PhD
11:15 Research Updates:
Neuroimaging Markers of Atypical Attentional Biases in Very Young Infants at High Risk for ASD
Mirella Dapretto, PhD
11:40 Break
Psychopharmacology
11:55 Clinical Perspectives:
Is There a Pill for That?: What We Know and Don’t Know about ASD Psychopharmacology
Benjamin Schneider, MD
12:20 Research Updates:
The Cutting-Edge of ASD Treatment Research
James McCracken, MD
12:45 Lunch
Biomarkers/Outcome Measures
2:00 Clinical Perspectives:
Outcome Measures in Autism: Challenges and Considerations
Charlotte DiStefano, PhD
2:25 Research Updates:
Biomarkers and Clinical Trials in Autism… On the Road to Precision Health
Shafali Spurling Jeste, MD
Behavioral Treatment
2:50 Clinical Perspectives:
Behavioral Treatments: How has it Changed and Where are We Going Next?
Amanda Gulsrud, PhD
3:15 Research Updates:
Adolescents with Autism Spectrum Disorder and Social Skills Groups at School: A Randomized Trial Comparing Intervention Environment and Peer Composition
Michelle Dean, PhD
3:40 Research Updates:
Evidence-Based Treatments to Improve Social Outcomes in Adults with ASD
Elizabeth Laugeson, PsyD
4:05 Break
Ask The Expert
4:20 Ask the Expert Panel

Facilitator: Shafali Spurling Jeste, MD
Panelists: Susan Bookheimer, PhD; Mirella Dapretto, PhD; Michelle Dean, PhD; Daniel H. Geschwind, MD, PhD; Amanda Gulsrud, PhD; Elizabeth Laugeson, PsyD; James McCracken, MD; Julian A. Martinez-Agosto, MD, PhD, FACMG, FAAP; Benjamin Schneider, MD
5:10 Closing Remarks
Daniel H. Geschwind, MD, PhD
5:20 Adjourn

At the completion of this course, participants should be able to:

  • Provide an update on the diagnostic and clinical utility of genetic testing in patients with autism. We will review genetic diagnostic tests available, challenges of their interpretation, and their impact on clinical management.
  • Describe methods in brain imaging and recent insights gained in imaging high risk infants and children with ASD
  • Review the neurobiologic pathways being targeted by new ASD treatment studies
  • Define biomarkers and understand how they can improve our clinical trials in ASD
  • Review best practices for clinical care of individuals with ASD across the lifespan

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.

Program Location
Tamkin Auditorium
Ronald Reagan UCLA Medical Center
757 Westwood Plaza
Los Angeles, CA 90095



Directions and Parking
From the 405 freeway, exit Wilshire Blvd., east toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. Pay per license plate at the kiosk and display the parking permit on your dash. All day parking is $12.00. The Ronald Reagan UCLA Medical Center is located on the corner of Westwood Plaza and Charles E. Young Dr. South.